Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07590167 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C
Trial Details
NCT Number NCT07590167
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Dyslipidemia, Hypertension
Related terms Dyslipidemias, Hypertension
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov